Search Results - "Tang, O. S."

Refine Results
  1. 1

    Survival analysis and causes of mortality in patients with lupus nephritis by YAP, Desmond YH, TANG, Colin S. O, MA, Maggie K. M, MAN FAI LAM, TAK MAO CHAN

    Published in Nephrology, dialysis, transplantation (01-08-2012)
    “…This study aimed to define the causes and associated risks of death compared with the local general population in Chinese patients with lupus nephritis in the…”
    Get full text
    Journal Article
  2. 2

    Misoprostol: Pharmacokinetic profiles, effects on the uterus and side-effects by Tang, O.S, Gemzell-Danielsson, K, Ho, P.C

    “…Abstract Misoprostol, a synthetic prostaglandin E1 analogue, is commonly used for medical abortion, cervical priming, the management of miscarriage, induction…”
    Get full text
    Journal Article
  3. 3

    Acquired C1-inhibitor deficiency in chronic lymphocytic leukaemia: a case report by Tang, A S O, Wong, Q Y, Yeo, S T, Lee, J T H, Leong, T S, Chew, L P

    “…The patient screened seronegative for human immunodeficiency virus, syphilis, and hepatitis B and C. Overall findings were consistent with a diagnosis of CLL…”
    Get full text
    Journal Article
  4. 4

    Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis by Yap, Desmond Y H, Tam, Chun Hay, Yung, Susan, Wong, Sunny, Tang, Colin S O, Mok, Temy M Y, Yuen, Catherine K Y, Ma, Maggie K M, Lau, Chak Sing, Chan, Tak Mao

    Published in Nephrology, dialysis, transplantation (01-05-2020)
    “…Abstract Background There is little data on mycophenolic acid (MPA) pharmacokinetics and pharmacogenomics and optimal MPA exposure in lupus nephritis (LN)…”
    Get full text
    Journal Article
  5. 5

    A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion by Chai, J., Tang, O.S., Hong, Q.Q., Chen, Q.F., Cheng, L.N., Ng, E., Ho, P.C.

    Published in Human reproduction (Oxford) (01-02-2009)
    “…BACKGROUND The conventional timing of misoprostol administration after mifepristone for second trimester medical abortion is 36–48 h, but simultaneous…”
    Get full text
    Journal Article
  6. 6

    A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade by Tse, K C, Lam, M F, Tang, S CW, Tang, C SO, Chan, T M

    Published in Lupus (01-01-2007)
    “…Persistent proteinuria in patients with quiescent lupus can result from membranous lupus nephritis and/or glomerular scarring following previous flares. This…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Cervical priming with misoprostol prior to transcervical procedures by Fiala, C, Gemzell-Danielsson, K, Tang, O.S, von Hertzen, H

    “…Abstract Cervical priming with misoprostol has shown to facilitate transcervical procedures and to reduce side-effects. Cervical priming is recommended by…”
    Get full text
    Journal Article
  9. 9

    Effect of letrozole on uterine artery Doppler flow indices prior to first‐trimester termination of pregnancy: a randomized controlled trial by Lee, V. C. Y., Yeung, T. W. Y., Tang, O. S., Ng, E. H. Y., Yeung, W. S. B., HO, P. C.

    Published in Ultrasound in obstetrics & gynecology (01-10-2012)
    “…Objective We previously demonstrated that a sequential regimen of letrozole and misoprostol resulted in a marked reduction in the serum estradiol concentration…”
    Get full text
    Journal Article
  10. 10

    Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy by Faúndes, A, Fiala, C, Tang, O.S, Velasco, A

    “…Abstract The aim was to review the current knowledge about the use of misoprostol alone for abortion induction during the first 12 weeks of pregnancy…”
    Get full text
    Journal Article
  11. 11

    Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis by Yap, Desmond Y H, Ma, Maggie K M, Mok, Maggie M Y, Tang, Colin S O, Chan, Tak Mao

    Published in Rheumatology (Oxford, England) (01-03-2013)
    “…We investigated the long-term outcome of patients with proliferative LN treated with CSs and MMF. This was a single-centre retrospective study on patients with…”
    Get full text
    Journal Article
  12. 12

    Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B by Tse, Kai Chung, Yap, Desmond Y. H., Tang, Colin S. O., Yung, Susan, Chan, Tak Mao

    Published in Clinical transplantation (01-03-2010)
    “…Tse KC, Yap DYH, Tang CSO, Yung S, Chan TM. Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine‐resistant…”
    Get full text
    Journal Article
  13. 13

    Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks by Ho, P.C, Blumenthal, P.D, Gemzell-Danielsson, K, Gómez Ponce de León, R, Mittal, S, Tang, O.S

    “…Abstract A combination of mifepristone and misoprostol is the regimen of choice for termination of pregnancy between 13 to 26 weeks. In many countries,…”
    Get full text
    Journal Article
  14. 14

    Ultrasound-guided embryo transfer: a prospective randomized controlled trial by Tang, Oi Shan, Ng, Ernest Hung Yu, So, William Wai Kei, Ho, Pak Chung

    Published in Human reproduction (Oxford) (01-11-2001)
    “…BACKGROUND: Recent reports suggested that ultrasound guidance during embryo transfer might improve the pregnancy rate. METHODS: A prospective randomized…”
    Get full text
    Journal Article
  15. 15

    Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability by Ngai, S.W., Tang, O.S., Chan, Y.M., Ho, P.C.

    Published in Human reproduction (Oxford) (01-05-2000)
    “…Misoprostol and mifepristone have been shown to be effective for medical abortion up to 9 weeks of gestation. When used alone, the successful complete abortion…”
    Get full text
    Journal Article
  16. 16

    Pilot study on the use of sublingual misoprostol for medical abortion by Tang, O.S., Ho, P.C.

    Published in Contraception (Stoneham) (01-11-2001)
    “…A new route of sublingual administration of misoprostol was used by 25 women with first trimester, non-viable intrauterine gestation and by 18 women requesting…”
    Get full text
    Journal Article
  17. 17

    A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor by Lam, H, Tang, O S, Lee, C P, Ho, P C

    “…To compare sublingual misoprostol with intravenous syntometrine use during third stage of labor by measuring the blood loss. Sixty women were randomized to…”
    Get more information
    Journal Article
  18. 18

    Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort study by Tang, O.S, Tang, G, Yip, P.S.F, Li, B

    Published in Contraception (Stoneham) (01-10-2000)
    “…Cross-sectional studies on the effects of depot-medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) have been controversial. The present…”
    Get full text
    Journal Article
  19. 19

    Vaginal misoprostol as medical treatment for first trimester spontaneous miscarriage by Ngai, Suk Wai, Chan, Yik Ming, Tang, Oi Shan, Ho, Pak Chung

    Published in Human reproduction (Oxford) (01-07-2001)
    “…BACKGROUND: Misoprostol is effective for cervical priming prior to suction evacuation in first trimester pregnancy termination. This is the first randomized…”
    Get full text
    Journal Article
  20. 20

    Long-term depot-medroxyprogesterone acetate and bone mineral density by Tang, O.S, Tang, G, Yip, P, Li, B, Fan, S

    Published in Contraception (Stoneham) (1999)
    “…The association between long-term use of depot-medroxyprogesterone acetate (DMPA) and bone mineral density (BMD) has been controversial, as seen in three…”
    Get full text
    Journal Article